New Patent Granted in Japan: No. 7769386

We are pleased to announce that our new patent (No. 7769386) has been granted in Japan. This patent covers the effectiveness of our iTAP method even in cancer cells with limited target antigens for immunotoxin therapy. Moving forward, we aim to expand the application of iTAP technology to a broader range of targets and continue advancing the development of innovative cancer treatments.